Related Experiment Video
Updated: Oct 1, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation
Dietrich Conze1, Troy Krahl, Norman Kennedy
1Section of Immunobiology, Department of Medicine, University of Vermont, Burlington, VT 05405, USA.
Abstract:
The c-Jun NH(2)-terminal kinase (JNK) signaling pathway is induced by cytokines and stress stimuli and is implicated in cell death and differentiation, but the specific function of this pathway depends on the cell type. Here we examined the role of JNK1 and JNK2 in CD8(+) T cells. Unlike CD4(+) T cells, the absence of JNK2 causes increased interleukin (IL)-2 production and proliferation of CD8(+) T cells. In contrast, JNK1-deficient CD8(+) T cells are unable to undergo antigen-stimulated expansion in vitro, even in the presence of exogenous IL-2. The hypoproliferation of these cells is associated with impaired IL-2 receptor alpha chain (CD25) gene and cell surface expression. The reduced level of nuclear activating protein 1 (AP-1) complexes in activated JNK1-deficient CD8(+) T cells can account for the impaired IL-2 receptor alpha chain gene expression. Thus, JNK1 and JNK2 play different roles during CD8(+) T cell activation and these roles differ from those in CD4(+) T cells.
Insights
The c-Jun NH(2)-terminal kinase (JNK) signaling pathway has distinct roles in CD8(+) T cells. JNK1 deficiency impairs T cell expansion, while JNK2 deficiency enhances interleukin-2 production and proliferation.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- The c-Jun NH(2)-terminal kinase (JNK) signaling pathway is activated by cytokines and stress.
- JNK signaling plays roles in cell death and differentiation, with cell-type-specific functions.
- The specific roles of JNK1 and JNK2 in CD8(+) T cell activation are not fully understood.
Purpose of the Study:
- To investigate the distinct roles of JNK1 and JNK2 in CD8(+) T cell activation.
- To compare the functions of JNK1 and JNK2 in CD8(+) T cells with their known roles in CD4(+) T cells.
Main Methods:
- Utilized JNK1- and JNK2-deficient CD8(+) T cells in in vitro studies.
- Assessed interleukin-2 (IL-2) production and cell proliferation.
- Measured IL-2 receptor alpha chain (CD25) gene and surface expression.
- Analyzed nuclear activating protein 1 (AP-1) complexes.
Main Results:
- Absence of JNK2 in CD8(+) T cells led to increased IL-2 production and proliferation.
- JNK1-deficient CD8(+) T cells showed impaired antigen-stimulated expansion, even with exogenous IL-2.
- Hypoproliferation in JNK1-deficient cells was linked to reduced IL-2 receptor alpha chain (CD25) expression.
- Reduced nuclear AP-1 complexes in JNK1-deficient cells correlated with impaired CD25 gene expression.
Conclusions:
- JNK1 and JNK2 exhibit differential functions during CD8(+) T cell activation.
- The roles of JNK1 and JNK2 in CD8(+) T cells differ from those observed in CD4(+) T cells.
- JNK1 is crucial for CD8(+) T cell expansion via regulation of IL-2 receptor expression.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Positive Regulator Molecules
Positive Regulator Molecules
cAMP-dependent Protein Kinase Pathways